INGN
$6.20
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.
Recent News
Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y
INGN posts narrower Q4 loss and 2% revenue rise, but shares dip as U.S. sales and rentals weaken despite international strength.
Inogen, Inc. Q4 2025 Earnings Call Summary
Moby summary of Inogen, Inc.'s Q4 2025 earnings call
Inogen Q4 Earnings Call Highlights
Inogen (NASDAQ:INGN) executives highlighted improving profitability, international momentum, and a broadened product portfolio during the company’s fourth-quarter 2025 earnings call held February 24, 2026. Management also introduced 2026 revenue guidance and disclosed a new $30 million share repurch
Inogen Inc (INGN) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Initiatives ...
Inogen Inc (INGN) reports a 4% annual revenue increase and unveils a $30 million share repurchase program, signaling confidence in its growth strategy.
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates
Inogen (INGN) delivered earnings and revenue surprises of +27.78% and -0.34%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?